BlackRock
STLN

BlackRock’s Starling Oncology STLN Stock Holding History

BlackRock’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8M Buy
4,749,030
+333,163
+8% +$1.4M ﹤0.01% 3103
2026
Q1 		$13.6M Buy
4,415,867
+510,534
+13% +$1.57M ﹤0.01% 3309
2025
Q4 		$13.9M Buy
3,905,333
+470,458
+14% +$1.74M ﹤0.01% 3293
2025
Q3 		$12M Buy
3,434,875
+127,971
+4% +$438K ﹤0.01% 3360
2025
Q2 		$6.78M Buy
3,306,904
+3,044,554
+1,160% +$7.61M ﹤0.01% 3616
2025
Q1 		$299K Buy
262,350
+8,759
+3% +$6.78K ﹤0.01% 4529
2024
Q4 		$78.4K Buy
253,591
+651
+0.3% +$169 ﹤0.01% 4841
2024
Q3 		$82.7K Buy
252,940
+48,126
+23% +$19.9K ﹤0.01% 4713
2024
Q2 		$94.2K Buy
204,814
+55,383
+37% +$47.3K ﹤0.01% 4720
2024
Q1 		$236K Sell
149,431
-88,415
-37% -$168K ﹤0.01% 4551
2023
Q4 		$485K Hold
237,846
– – ﹤0.01% 4431
2023
Q3 		$333K Buy
237,846
+88,415
+59% +$91.5K ﹤0.01% 4533
2023
Q2 		$82.2K Sell
149,431
-774,486
-84% -$410K ﹤0.01% 4979
2023
Q1 		$626K Sell
923,917
-677,367
-42% -$864K ﹤0.01% 4478
2022
Q4 		$2.64M Buy
1,601,284
+71,634
+5% +$201K ﹤0.01% 4011
2022
Q3 		$7.08M Buy
1,529,650
+771,555
+102% +$4.54M ﹤0.01% 3600
2022
Q2 		$3.84M Buy
+758,095
New +$5.52M ﹤0.01% 3943

Other funds holding STLN

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return

BlackRock's STLN Position: Q2 2026 in Review

BlackRock increased its Starling Oncology (STLN) stake by 7.5% in Q2 2026, buying an estimated $1.4M and bringing the position to 4,749,030 shares worth $25.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3103.

BlackRock first reported a position in STLN in Q2 2022 and has held it in 17 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • BlackRock held 4,749,030 shares of Starling Oncology worth $25.8M as of Q2 2026.
  • BlackRock bought 333,163 Starling Oncology shares in Q2 2026, an estimated $1.4M.
  • Starling Oncology made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3103 holding.
  • BlackRock first reported a position in Starling Oncology in Q2 2022 and has held it in 17 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.